The renoprotective effects of EGCG might be realized by two pathways: one is functioning as a NADPH oxidase inhibitor, directly suppressing the production of ROS, and the other is inhibiting the expression of downstream molecules of Ang II mediated pathway, directly downregulating the production of effectors for renal fibrosis. The gene discussed is AGT; the disease is renal fibrosis.